Nicklaus Children's Hospital f/k/a Miami Children's Hospital

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Nicklaus Children's Hospital f/k/a Miami Children's Hospital sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).

9 total trials 1 currently recruiting 3 completed early-phase tilt top decile by trial count

Nicklaus Children's Hospital f/k/a Miami Children's Hospital: 9 sponsored US clinical trials, 1 recruiting.

Nicklaus Children's Hospital f/k/a Miami Children's Hospital sponsors 9 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. 1 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Genetic Syndrome, with 1 trials.

Top-decile sponsor footprint

Nicklaus Children's Hospital f/k/a Miami Children's Hospital ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

9 total, page 1 of 1

RECRUITING

Diagnostic Odyssey: Whole Genome Sequencing (WGS)

NCT03458962
NOT YET RECRUITING

Prospective Evaluation of Cardiac Point-of-Care Ultrasound (POCUS) Performed by PEM Fellows and Artificial Intelligence on Children With Pre-existing Cardiac Conditions.

NCT07503158
COMPLETED NA

Assess Patient Readiness for Pelvic Ultrasound With the Use of Artificial Intelligence

NCT07535294
TERMINATED Phase 1

Liposomal Bupivacaine Pharmacokinetic Study After Median Sternotomy Incision Infiltration in a Pediatric Cardiac Surgery

NCT04685421
TERMINATED NA

Comparing Speedlyte and IV Rehydration Treating Children With Gastroenteritis in a Pediatric Emergency Department (ED)

NCT03562702
TERMINATED NA

Ketogenic Diet in Children With Malignant or Recurrent/Refractory Brain Tumor

NCT03328858
COMPLETED Phase 4

Human Fibrinogen Concentrate in Pediatric Cardiac Surgery

NCT02822599
TERMINATED Phase 2

Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumors

NCT02684071
COMPLETED NA

Head Motion in Pediatric Patients Endotracheally Intubated With Video Laryngoscopy Versus Direct Laryngoscopy

NCT02405390

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1
Phase 4 1

Therapeutic Areas

Genetic Syndrome 1
Genetic Disease 1

What is open in the Nicklaus Children's Hospital f/k/a Miami Children's Hospital pipeline

1 recruiting of 9 indexed (11% open); 3 completed (33%).

Phase mix: 1 late (III/IV) vs 2 early (I/II) (early-phase heavy).

Top condition: Genetic Syndrome (1 trial), 1 other listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Nicklaus Children's Hospital f/k/a Miami Children's Hospital: open-pipeline peers nationwide

Peers matched on 9 registered trials and 11% open enrollment, not the therapeutic-area sidebar.

Nicklaus Children's Hospital f/k/a Miami Children's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 01020304050 0%10%20%30%40%50% Total trials Recruiting share Nicklaus Children's Hospital f/k/a Miami Children's Hospital4D Molecular Therapeutics9 Meters BiopharmaAadi BioscienceAblynx, a Sanofi companyADC Therapeutics S.A.Adrian VellaAIDS Malignancy ConsortiumAmylyx Pharmaceuticals
Nicklaus Children's Hospital f/k/a Miami Children's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Nicklaus Children's Hospital f/k/a Miami Children's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 9 trials (± recruiting share)

Sponsors near 11% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Nicklaus Children's Hospital f/k/a Miami Children's Hospital page

9 registered trials is a research-attention snapshot, not an endorsement of Nicklaus Children's Hospital f/k/a Miami Children's Hospital or any single study.

  • 1 of Nicklaus Children's Hospital f/k/a Miami Children's Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Genetic Syndrome is the condition Nicklaus Children's Hospital f/k/a Miami Children's Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Genetic Syndrome trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Nicklaus Children's Hospital f/k/a Miami Children's Hospital pipeline card: 9 registered trials from official public datasets.Report a data error.